Inflection Point [IPXX] vs SILVERspac [SLVR] Detailed Stock Comparison

Inflection Point

SILVERspac
TLDR: Quick Comparison Summary
We found some data (4 metrics), but not enough for a complete comparison. Metrics like P/E ratio, profitability, and financial health are still available in the detailed tabs below.
View Metrics Details
Vital Metrics Comparison
Note: Limited metrics are available for comparison. Check other tabs for more detailed analysis.
Metric | Inflection Point | SILVERspac | Better |
---|---|---|---|
P/E Ratio (TTM) | N/A | 46.14 | N/A |
Price-to-Book Ratio | 0.64 | 5.75 | Inflection Point |
Debt-to-Equity Ratio | 0.00 | 0.00 | Tie |
PEG Ratio | N/A | 0.31 | N/A |
EV/EBITDA | N/A | 0.00 | N/A |
Return on Equity | N/A | 3.80% | N/A |
Return on Assets (TTM) | N/A | 3.62% | N/A |
1-Year Return | 70.69% | 107.49% | SILVERspac |
Enterprise Value | $0 | $0 | Tie |
Revenue per Share (TTM) | N/A | $0 | N/A |
Earnings per Share (Diluted) | N/A | $0.29 | N/A |
Inflection Point vs SILVERspac Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Inflection Point | 14.31% | 49.80% | 88.66% | 161.43% | 299.38% | 109.86% |
SILVERspac | 2.93% | 2.12% | 19.88% | 44.13% | 94.98% | 106.91% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Inflection Point | 70.69% | 81.64% | 81.64% | 81.64% | 81.64% | 81.64% |
SILVERspac | 107.49% | 351.78% | 355.97% | 355.97% | 355.97% | 355.97% |
News Based Sentiment: Inflection Point vs SILVERspac
Inflection Point
News based Sentiment: NEUTRAL
The month's narrative centers around increased visibility for IPXX as a small-cap stock, but the reports also highlight the inherent risks of this market segment. While positive in terms of attention, the overall impact on the investment case is neutral, requiring further investigation.
SILVERspac
News based Sentiment: MIXED
September was a pivotal month for Silver Tiger Metals, marked by a successful financing round that addressed liquidity concerns but also introduced dilution. While analysts are optimistic about long-term profitability, significant risks remain regarding the company's ability to achieve its ambitious growth targets and generate substantial revenue.
Performance & Financial Health Analysis: Inflection Point vs SILVERspac
Metric | IPXX | SLVR |
---|---|---|
Market Information | ||
Market Cap | $811.25M | $1.11B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 11,317,539 | 401,900 |
90 Day Avg. Volume | 6,956,464 | 275,173 |
Last Close | $25.96 | $45.62 |
52 Week Range | $5.56 - $28.25 | $19.66 - $46.67 |
% from 52W High | -8.11% | -2.24% |
All-Time High | $28.25 (Oct 03, 2025) | $46.67 (Oct 06, 2025) |
% from All-Time High | -8.11% | -2.25% |
Growth Metrics | ||
Quarterly Revenue Growth | N/A | N/A |
Quarterly Earnings Growth | N/A | N/A |
Financial Health | ||
Profit Margin (TTM) | N/A | N/A |
Operating Margin (TTM) | N/A | N/A |
Return on Equity (TTM) | N/A | 0.04% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $40.57 | $7.95 |
Cash per Share (MRQ) | $0.02 | $0.00 |
Operating Cash Flow (TTM) | $0 | $5.81M |
Levered Free Cash Flow (TTM) | $0 | $9.20M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Inflection Point vs SILVERspac
Metric | IPXX | SLVR |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | N/A | 46.14 |
Forward P/E | N/A | N/A |
PEG Ratio | N/A | 0.31 |
Price to Sales (TTM) | N/A | N/A |
Price to Book (MRQ) | 0.64 | 5.75 |
Market Capitalization | ||
Market Capitalization | $811.25M | $1.11B |
Enterprise Value | $0 | $0 |
Enterprise Value Metrics | ||
Enterprise to Revenue | N/A | N/A |
Enterprise to EBITDA | N/A | 0.00 |
Risk & Other Metrics | ||
Beta | N/A | N/A |
Book Value per Share (MRQ) | $40.57 | $7.95 |
Financial Statements Comparison: Inflection Point vs SILVERspac
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | IPXX | SLVR |
---|---|---|
Revenue/Sales | $0 | N/A |
Cost of Goods Sold | N/A | N/A |
Gross Profit | N/A | N/A |
Research & Development | N/A | N/A |
Operating Income (EBIT) | $-1.92M | N/A |
EBITDA | $-5.35M | N/A |
Pre-Tax Income | $1.51M | N/A |
Income Tax | N/A | N/A |
Net Income (Profit) | $1.51M | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | IPXX | SLVR |
---|---|---|
Cash & Equivalents | $141,201 | N/A |
Total Current Assets | $222,948 | N/A |
Total Current Liabilities | $2.73M | N/A |
Long-Term Debt | N/A | N/A |
Total Shareholders Equity | $253.54M | N/A |
Retained Earnings | $-15.60M | N/A |
Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | IPXX | SLVR |
---|---|---|
Operating Cash Flow | $1.51M | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | $-490,386 | N/A |
Debt Repayment | $0 | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | IPXX | SLVR |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 11,317,539 | 401,900 |
Average Daily Volume (90 Day) | 6,956,464 | 275,173 |
Shares Outstanding | 31.25M | 25.00M |
Float Shares | N/A | N/A |
% Held by Insiders | N/A | N/A |
% Held by Institutions | N/A | N/A |
Dividend Analysis & Yield Comparison: Inflection Point vs SILVERspac
Metric | IPXX | SLVR |
---|---|---|
Last 12-Month Dividend | N/A | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | N/A |
Ex-Dividend Date | N/A | N/A |